182 related articles for article (PubMed ID: 27600819)
1. Development and in-vitro characterization of sorbitan monolaurate and poloxamer 184 based niosomes for oral delivery of diacerein.
Khan MI; Madni A; Peltonen L
Eur J Pharm Sci; 2016 Dec; 95():88-95. PubMed ID: 27600819
[TBL] [Abstract][Full Text] [Related]
2. Ultrasonic Processing Technique as a Green Preparation Approach for Diacerein-Loaded Niosomes.
Khan MI; Madni A; Hirvonen J; Peltonen L
AAPS PharmSciTech; 2017 Jul; 18(5):1554-1563. PubMed ID: 27604883
[TBL] [Abstract][Full Text] [Related]
3. The Impact of Surfactant Composition and Surface Charge of Niosomes on the Oral Absorption of Repaglinide as a BCS II Model Drug.
Yaghoobian M; Haeri A; Bolourchian N; Shahhosseni S; Dadashzadeh S
Int J Nanomedicine; 2020; 15():8767-8781. PubMed ID: 33204087
[TBL] [Abstract][Full Text] [Related]
4. Design and in vitro characterization of small unilamellar niosomes as ophthalmic carrier of dorzolamide hydrochloride.
Hasan AA
Pharm Dev Technol; 2014 Sep; 19(6):748-54. PubMed ID: 23964893
[TBL] [Abstract][Full Text] [Related]
5. QbD based development of proliposome of lopinavir for improved oral bioavailability.
Patel GM; Shelat PK; Lalwani AN
Eur J Pharm Sci; 2017 Oct; 108():50-61. PubMed ID: 27586019
[TBL] [Abstract][Full Text] [Related]
6. Physicochemical properties and skin permeation of Span 60/Tween 60 niosomes of ellagic acid.
Junyaprasert VB; Singhsa P; Suksiriworapong J; Chantasart D
Int J Pharm; 2012 Feb; 423(2):303-11. PubMed ID: 22155414
[TBL] [Abstract][Full Text] [Related]
7. Implementing Central Composite Design for Developing Transdermal Diacerein-Loaded Niosomes: Ex vivo Permeation and In vivo Deposition.
Aziz DE; Abdelbary AA; Elassasy AI
Curr Drug Deliv; 2018; 15(9):1330-1342. PubMed ID: 29921206
[TBL] [Abstract][Full Text] [Related]
8. Utilization of green formulation technique and efficacy estimation on cell line studies for dual anticancer drug therapy with niosomes.
Khan DH; Bashir S; Correia A; Khan MI; Figueiredo P; Santos HA; Peltonen L
Int J Pharm; 2019 Dec; 572():118764. PubMed ID: 31628977
[TBL] [Abstract][Full Text] [Related]
9. α-Tocopherol-loaded niosome prepared by heating method and its release behavior.
Basiri L; Rajabzadeh G; Bostan A
Food Chem; 2017 Apr; 221():620-628. PubMed ID: 27979250
[TBL] [Abstract][Full Text] [Related]
10. Novel bicephalous heterolipid based self-microemulsifying drug delivery system for solubility and bioavailability enhancement of efavirenz.
Chaudhari KS; Akamanchi KG
Int J Pharm; 2019 Apr; 560():205-218. PubMed ID: 30742985
[TBL] [Abstract][Full Text] [Related]
11. Novel self-nanoemulsifying self-nanosuspension (SNESNS) for enhancing oral bioavailability of diacerein: Simultaneous portal blood absorption and lymphatic delivery.
El-Laithy HM; Basalious EB; El-Hoseiny BM; Adel MM
Int J Pharm; 2015 Jul; 490(1-2):146-54. PubMed ID: 26002566
[TBL] [Abstract][Full Text] [Related]
12. Formulation and optimization of niosomes for topical diacerein delivery using 3-factor, 3-level Box-Behnken design for the management of psoriasis.
Moghddam SR; Ahad A; Aqil M; Imam SS; Sultana Y
Mater Sci Eng C Mater Biol Appl; 2016 Dec; 69():789-97. PubMed ID: 27612773
[TBL] [Abstract][Full Text] [Related]
13. Sorbitane Monostearate and Cholesterol based Niosomes for Oral Delivery of Telmisartan.
Ahad A; Raish M; Al-Jenoobi FI; Al-Mohizea AM
Curr Drug Deliv; 2018 Feb; 15(2):260-266. PubMed ID: 28521674
[TBL] [Abstract][Full Text] [Related]
14. PEGylated non-ionic surfactant vesicles as drug delivery systems for Gambogenic acid.
Lin T; Fang Q; Peng D; Huang X; Zhu T; Luo Q; Zhou K; Chen W
Drug Deliv; 2013; 20(7):277-84. PubMed ID: 24044645
[TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of proliposomes and self micro-emulsifying drug delivery system for improved oral bioavailability of nisoldipine.
Nekkanti V; Rueda J; Wang Z; Betageri GV
Int J Pharm; 2016 May; 505(1-2):79-88. PubMed ID: 27041124
[TBL] [Abstract][Full Text] [Related]
16. Formulation and characterization of drug loaded nonionic surfactant vesicles (niosomes) for oral bioavailability enhancement.
Kamboj S; Saini V; Bala S
ScientificWorldJournal; 2014; 2014():959741. PubMed ID: 24672401
[TBL] [Abstract][Full Text] [Related]
17. Diacerein niosomal gel for topical delivery: development, in vitro and in vivo assessment.
El-Say KM; Abd-Allah FI; Lila AE; Hassan Ael-S; Kassem AE
J Liposome Res; 2016; 26(1):57-68. PubMed ID: 25853339
[TBL] [Abstract][Full Text] [Related]
18. Oral delivery of allopurinol niosomes in treatment of gout in animal model.
Singh N; Parashar P; Tripathi CB; Kanoujia J; Kaithwas G; Saraf SA
J Liposome Res; 2017 Jun; 27(2):130-138. PubMed ID: 28067087
[TBL] [Abstract][Full Text] [Related]
19. Calcium alginate microspheres containing metformin hydrochloride niosomes and chitosomes aimed for oral therapy of type 2 diabetes mellitus.
Maestrelli F; Mura P; González-Rodríguez ML; Cózar-Bernal MJ; Rabasco AM; Di Cesare Mannelli L; Ghelardini C
Int J Pharm; 2017 Sep; 530(1-2):430-439. PubMed ID: 28778628
[TBL] [Abstract][Full Text] [Related]
20. Influence of a niosomal formulation on the oral bioavailability of acyclovir in rabbits.
Attia IA; El-Gizawy SA; Fouda MA; Donia AM
AAPS PharmSciTech; 2007 Dec; 8(4):E106. PubMed ID: 18181527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
